Gena Wang Recent News
Jefferies Highlights Clinically Meaningful Data From Ultragenyx On KRN23
Jefferies Examines The Effect Of Sarepta's Drug Approval On PTC Therapeutics
Jefferies Upgrades Editas Medicine To Buy, Positive On Partnerships & Progress On LCA 10 IND Testing
Sarepta Shares Under Pressure As Jefferies Downgrades To Underperform
PTC Therapeutics: Oppenheimer Bull Cuts Target From $111 To $39; Jefferies Less Certain on Translarna
Jefferies Upgrades PTC Therapeutics To Hold; Sees FDA Approvalability Priced In And Is Uncertain On EU Decision
Leerink: Pharmacyclics Is Now Worth $240
Why OvaScience Shares Soared 35%